1 Rakha EA, "The prognostic significance of lymphovascular invasion in invasive breast carcinoma" 118 : 3670-3680, 2012
2 Huston TL, "The presentation of contralateral axillary lymph node metastases from breast carcinoma : a clinical management dilemma" 13 : 158-164, 2007
3 Boughey JC, "Sentinel lymph node surgery in locally recurrent breast cancer" 7 : 248-253, 2006
4 Ucmak Vural G, "Sentinel lymph node detection in contralateral axilla at initial presentation of a breast cancer patient : case report" 24 : 90-93, 2015
5 Kelemen PR, "Positron emission tomography and sentinel lymph node dissection in breast cancer" 3 : 73-77, 2002
6 Groheux D, "Performance of FDG PET/CT in the clinical management of breast cancer" 266 : 388-405, 2013
7 Tokmak H, "Management of sentinel node re-mapping in patients who have second or recurrent breast cancer and had previous axillary procedures" 12 : 205-, 2014
8 WangW, "Management of contralateral axillary lymph node metastasis frombreast cancer : a clinical dilemma" 100 : 600-604, 2014
9 Moncayo VM, "Lymphoscintigraphy and sentinel nodes" 56 : 901-907, 2015
10 Maaskant-Braat AJ, "Lymphaticmapping after previous breast surgery" 21 : 444-448, 2012
1 Rakha EA, "The prognostic significance of lymphovascular invasion in invasive breast carcinoma" 118 : 3670-3680, 2012
2 Huston TL, "The presentation of contralateral axillary lymph node metastases from breast carcinoma : a clinical management dilemma" 13 : 158-164, 2007
3 Boughey JC, "Sentinel lymph node surgery in locally recurrent breast cancer" 7 : 248-253, 2006
4 Ucmak Vural G, "Sentinel lymph node detection in contralateral axilla at initial presentation of a breast cancer patient : case report" 24 : 90-93, 2015
5 Kelemen PR, "Positron emission tomography and sentinel lymph node dissection in breast cancer" 3 : 73-77, 2002
6 Groheux D, "Performance of FDG PET/CT in the clinical management of breast cancer" 266 : 388-405, 2013
7 Tokmak H, "Management of sentinel node re-mapping in patients who have second or recurrent breast cancer and had previous axillary procedures" 12 : 205-, 2014
8 WangW, "Management of contralateral axillary lymph node metastasis frombreast cancer : a clinical dilemma" 100 : 600-604, 2014
9 Moncayo VM, "Lymphoscintigraphy and sentinel nodes" 56 : 901-907, 2015
10 Maaskant-Braat AJ, "Lymphaticmapping after previous breast surgery" 21 : 444-448, 2012
11 Roumen RM, "Lymphatic mapping and sentinel node harvesting in patients with recurrent breast cancer" 32 : 1076-1081, 2006
12 Estourgie SH, "Lymphatic drainage patterns from the breast" 239 : 232-237, 2004
13 Son YG, "Is it contralateral axillary metastasis or occult breast cancer? : a confusing case report" 8 : 498-502, 2015
14 Kumar R, "FDG PET positive lymph nodes are highly predictive of metastasis in breast cancer" 27 : 231-236, 2006
15 Moossdorff M, "Contralateral lymph node recurrence in breast cancer: regional event rather than distant metastatic disease. A systematic review of the literature" 41 : 1128-1136, 2015
16 Morcos B, "Characteristics of and therapeutic options for contralateral axillary lymph node metastasis in breast cancer" 37 : 418-421, 2011
17 오창모, "Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2013" 대한암학회 48 (48): 436-450, 2016
18 van Maaren MC, "Breast-conserving therapy versus mastectomy in T1-2N2 stage breast cancer : a population-based study on 10-year overall, relative, and distant metastasis-free survival in 3071 patients" 160 : 511-521, 2016
19 Fehr MK, "Axillary staging using positron emission tomography in breast cancer patients qualifying for sentinel lymph node biopsy" 10 : 89-93, 2004
20 Groheux D, "18F-FDG PET/CT for staging and restaging of breast cancer" 57 (57): 17S-26S, 2016